Free Trial
→ Here’s How to Claim Your Stake in Elon’s Private Company, xAI (From Brownstone Research) (Ad) Buy ABBV Stock  Free ABBV Stock Alerts

AbbVie (ABBV) Short Interest Ratio & Short Volume

AbbVie logo
$198.62 +5.28 (+2.73%)
Closing price 05/2/2025 03:59 PM Eastern
Extended Trading
$197.95 -0.67 (-0.34%)
As of 06:43 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

AbbVie Short Interest Data

AbbVie (ABBV) has a short interest of 16.84 million shares, representing 0.96% of the float (the number of shares available for trading by the public). This marks a -1.75% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.3, indicating that it would take 2.3 days of the average trading volume of 6.06 million shares to cover all short positions.

Current Short Interest
16,840,000 shares
Previous Short Interest
17,140,000 shares
Change Vs. Previous Month
-1.75%
Dollar Volume Sold Short
$2.98 billion
Short Interest Ratio
2.3 Days to Cover
Last Record Date
April 15, 2025
Outstanding Shares
1,768,978,000 shares
Short Percent of Float
0.96%
Today's Trading Volume
6,424,665 shares
Average Trading Volume
6,057,670 shares
Today's Volume Vs. Average
106%
Short Selling AbbVie?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for AbbVie and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

ABBV Short Interest Over Time

ABBV Days to Cover Over Time

ABBV Percentage of Float Shorted Over Time

AbbVie Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/15/202516,840,000 shares $2.98 billion -1.8%1.0%2.3 $176.84
3/31/202517,140,000 shares $3.60 billion -13.0%1.0%2.4 $209.83
3/15/202519,700,000 shares $4.17 billion +6.4%1.1%3.1 $211.90
2/28/202518,510,000 shares $3.87 billion -5.7%1.1%3 $209.07
2/15/202519,620,000 shares $3.79 billion +3.7%1.1%3.3 $193.00
1/31/202518,930,000 shares $3.48 billion +4.2%1.1%2.9 $183.90
1/15/202518,160,000 shares $3.11 billion +6.8%N/A2.8 $171.32
12/31/202417,000,000 shares $3.02 billion -8.3%N/A2.7 $177.70
12/15/202418,530,000 shares $3.21 billion -4.1%N/A3 $173.37
11/30/202419,320,000 shares $3.53 billion -4.2%N/A3.3 $182.93
11/15/202420,170,000 shares $3.33 billion +11.3%N/A3.5 $164.91
10/31/202418,130,000 shares $3.70 billion +12.1%N/A3.7 $203.87
10/15/202416,180,000 shares $3.10 billion +8.9%0.9%3.4 $191.86
9/30/202414,860,000 shares $2.93 billion -16.5%0.8%3.2 $197.48
9/15/202417,790,000 shares $3.45 billion -8.7%1.0%3.5 $194.21
8/31/202419,490,000 shares $3.83 billion -3.5%1.1%3.7 $196.31
8/15/202420,190,000 shares $3.90 billion +15.2%1.2%3.7 $193.40
7/31/202417,530,000 shares $3.25 billion +7.0%1.0%3.2 $185.32
7/15/202416,380,000 shares $2.75 billion +1.0%0.9%3 $168.03
6/30/202416,220,000 shares $2.78 billion +6.4%0.9%3 $171.52
6/15/202415,250,000 shares $2.57 billion -7.5%0.9%2.9 $168.59
5/31/202416,490,000 shares $2.66 billion +3.5%0.9%2.9 $161.19
5/15/202415,930,000 shares $2.61 billion +10.0%0.9%2.9 $163.78
4/30/202414,480,000 shares $2.36 billion +6.9%0.8%2.6 $162.69
4/15/202413,540,000 shares $2.19 billion +3.2%N/A2.4 $161.67
3/31/202413,120,000 shares $2.39 billion -10.7%N/A2.3 $182.10
3/15/202414,690,000 shares $2.61 billion +2.9%0.8%2.7 $177.88
2/29/202414,270,000 shares $2.51 billion -3.3%0.8%2.6 $175.61
2/15/202414,750,000 shares $2.60 billion +7.5%0.8%2.8 $176.61
1/31/202413,720,000 shares $2.26 billion +1.2%0.8%2.5 $164.36
1/15/202413,560,000 shares $2.20 billion +12.3%0.8%2.4 $162.40
12/31/202312,080,000 shares $1.87 billion -11.8%0.7%2.2 $154.97
12/15/202313,690,000 shares $2.11 billion +23.0%0.8%2.6 $154.07
11/30/202311,130,000 shares $1.58 billion -0.2%0.6%2.2 $142.35
11/15/202311,150,000 shares $1.53 billion -15.7%0.6%2.4 $137.61
10/31/202313,230,000 shares $1.87 billion +15.3%0.8%3 $141.18
10/15/202311,470,000 shares $1.70 billion -6.8%0.7%2.6 $147.96
9/30/202312,310,000 shares $1.83 billion +3.2%0.7%2.7 $149.06
9/15/202311,930,000 shares $1.81 billion -4.2%0.7%2.4 $152.09
8/31/202312,450,000 shares $1.83 billion -6.1%0.7%2.4 $146.96
Here’s How to Claim Your Stake in Elon’s Private Company, xAI (Ad)

Even though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks like you… To partner with Elon on what he believes will be the biggest AI project of the century… Starting with as little as $500.

Click here to see how you could take a stake in Elon’s private company…
8/15/202313,260,000 shares $2.02 billion +15.9%0.8%2.3 $152.12
7/31/202311,440,000 shares $1.71 billion +20.3%0.7%2 $149.58
7/15/20239,510,000 shares $1.29 billion -8.2%0.5%1.6 $136.01
6/30/202310,360,000 shares $1.40 billion -8.4%0.6%1.8 $134.72
6/15/202311,310,000 shares $1.54 billion -0.6%0.6%2 $135.89
5/31/202311,380,000 shares $1.57 billion -4.9%0.7%1.9 $137.96
5/15/202311,970,000 shares $1.75 billion -23.5%0.7%2.1 $146.59
4/30/202315,650,000 shares $2.37 billion +3.4%0.9%2.6 $151.12
4/15/202315,140,000 shares $2.45 billion -7.0%N/A2.6 $161.59
3/31/202316,280,000 shares $2.59 billion +16.0%N/A2.6 $159.37
3/15/202314,040,000 shares $2.16 billion +10.6%N/A2.3 $154.06
2/28/202312,700,000 shares $1.95 billion +8.5%N/A2.3 $153.90
2/15/202311,710,000 shares $1.77 billion +13.7%N/A2.1 $151.06
1/31/202310,300,000 shares $1.52 billion -13.9%N/A1.8 $147.75
1/15/202311,960,000 shares $1.84 billion -7.5%N/A2.2 $153.60
12/30/202212,930,000 shares $2.09 billion -4.8%N/A2.5 $161.61
12/15/202213,580,000 shares $2.21 billion -0.6%N/A2.4 $163.10
11/30/202213,660,000 shares $2.20 billion +5.8%N/A2.4 $161.18
11/15/202212,910,000 shares $1.98 billion -6.5%N/A2.3 $153.04
10/31/202213,800,000 shares $2.02 billion -1.4%N/A2.6 $146.40
10/15/202214,000,000 shares $2.00 billion +5.3%N/A2.6 $142.94
9/30/202213,290,000 shares $1.78 billion +2.6%N/A2.4 $134.21
9/15/202212,950,000 shares $1.85 billion +13.8%N/A2.4 $142.51
8/31/202211,380,000 shares $1.53 billion -12.5%N/A2.1 $134.46
8/15/202213,010,000 shares $1.85 billion -6.1%N/A2.2 $142.29
7/31/202213,850,000 shares $1.99 billion -1.3%0.8%2.2 $143.51
7/15/202214,030,000 shares $2.16 billion -2.7%0.8%2.1 $153.62
6/30/202214,420,000 shares $2.21 billion +6.7%1.0%2 $153.16
6/15/202213,520,000 shares $1.87 billion +6.0%0.9%1.9 $138.09
5/31/202212,750,000 shares $1.88 billion -10.4%0.7%1.8 $147.37
5/15/202214,230,000 shares $2.18 billion +8.2%0.8%1.9 $153.50
4/30/202213,150,000 shares $1.93 billion +9.0%0.8%1.7 $146.88
4/15/202212,070,000 shares $1.96 billion -10.2%0.7%1.5 $162.31
3/31/202213,440,000 shares $2.18 billion -9.7%0.8%1.7 $162.11
3/15/202214,890,000 shares $2.32 billion -6.9%N/A1.9 $155.88
2/28/202215,990,000 shares $2.36 billion +3.9%N/A2 $147.77
2/15/202215,390,000 shares $2.23 billion -4.7%N/A2 $144.76
1/31/202216,150,000 shares $2.21 billion +12.7%0.9%2.3 $136.89
1/15/202214,330,000 shares $1.95 billion -13.7%0.8%2.2 $135.87
12/31/202116,610,000 shares $2.25 billion +7.6%0.9%2.7 $135.40
12/15/202115,440,000 shares $2.01 billion +9.4%0.9%2.5 $130.23
11/30/202114,120,000 shares $1.63 billion +0.2%N/A2.3 $115.28
11/15/202114,090,000 shares $1.65 billion +3.5%0.8%2 $116.84
10/29/202113,620,000 shares $1.56 billion +18.5%0.8%1.9 $114.67
10/15/202111,490,000 shares $1.26 billion -16.0%0.7%1.6 $109.33
9/30/202113,670,000 shares $1.47 billion +5.2%0.8%1.9 $107.87
9/15/202112,990,000 shares $1.40 billion -4.1%0.7%1.9 $107.77
8/31/202113,550,000 shares $1.64 billion +3.5%0.8%2 $120.78
8/13/202113,090,000 shares $1.52 billion -9.4%0.7%2.2 $116.48
7/30/202114,450,000 shares $1.68 billion -1.4%0.8%2.3 $116.30
Here’s How to Claim Your Stake in Elon’s Private Company, xAI (Ad)

Even though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks like you… To partner with Elon on what he believes will be the biggest AI project of the century… Starting with as little as $500.

Click here to see how you could take a stake in Elon’s private company…
7/15/202114,660,000 shares $1.72 billion +6.5%0.8%2.3 $117.18
6/30/202113,770,000 shares $1.55 billion +3.2%0.8%2.2 $112.64
6/15/202113,340,000 shares $1.55 billion -9.6%0.8%2 $115.83
5/28/202114,760,000 shares $1.67 billion -3.4%0.8%2.1 $113.20
5/14/202115,280,000 shares $1.78 billion +2.6%N/A2.2 $116.60
4/30/202114,890,000 shares $1.65 billion -20.4%N/A2.2 $110.89
4/15/202118,710,000 shares $1.98 billion +11.4%N/A2.6 $105.90
3/31/202116,800,000 shares $1.79 billion +3.7%N/A2.3 $106.79
3/15/202116,200,000 shares $1.75 billion +5.0%N/A2.2 $108.22
2/26/202115,430,000 shares $1.66 billion +8.1%N/A2.2 $107.33
2/12/202114,280,000 shares $1.48 billion -4.0%N/A1.9 $103.75
1/29/202114,870,000 shares $1.55 billion +18.1%N/A1.9 $104.21
1/15/202112,590,000 shares $1.41 billion -5.6%N/A1.5 $111.63
12/31/202013,330,000 shares $1.40 billion -3.8%N/A1.6 $105.27
12/15/202013,850,000 shares $1.44 billion +4.4%N/A1.7 $104.20
11/30/202013,270,000 shares $1.39 billion -5.2%N/A1.6 $104.89
11/15/202014,000,000 shares $1.39 billion +9.0%N/A1.7 $99.04
10/30/202012,840,000 shares $1.04 billion +20.7%N/A1.6 $80.67
10/15/202010,640,000 shares $915.78 million -17.8%N/A1.5 $86.07
9/30/202012,940,000 shares $1.13 billion -2.6%N/A1.9 $87.59
9/15/202013,280,000 shares $1.21 billion +9.2%N/A1.9 $90.91
8/31/202012,160,000 shares $1.16 billion -2.0%N/A1.7 $95.77
8/14/202012,410,000 shares $1.18 billion -6.3%N/A1.7 $95.07
7/31/202013,240,000 shares $1.26 billion -3.2%N/A1.5 $94.91
7/15/202013,680,000 shares $1.37 billion -15.6%N/A1.4 $100.48
6/30/202016,210,000 shares $1.59 billion -18.0%N/A1.6 $98.18
6/15/202019,760,000 shares $1.84 billion +2.9%N/A1.8 $93.08
5/29/202019,200,000 shares $1.78 billion -22.6%N/A1.5 $92.67
5/15/202024,800,000 shares $2.25 billion -70.9%N/A1.8 $90.71

ABBV Short Interest - Frequently Asked Questions

What is AbbVie's current short interest?

Short interest is the volume of AbbVie shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 16,840,000 shares of ABBV short. 0.96% of AbbVie's shares are currently sold short. Learn More on AbbVie's current short interest.

What is a good short interest ratio for AbbVie?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ABBV shares currently have a short interest ratio of 2.0. Learn More on AbbVie's short interest ratio.

Which institutional investors are shorting AbbVie?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of AbbVie: Portman Square Capital LLP, SteelPeak Wealth LLC, Fulcrum Asset Management LLP, SG Americas Securities LLC, IMC Chicago LLC, CenterStar Asset Management LLC, Wealth Enhancement Advisory Services LLC, NorthCrest Asset Manangement LLC, Wolverine Trading LLC, Squarepoint Ops LLC, Royal Bank of Canada, Man Group plc, Nomura Holdings Inc., Maven Securities LTD, Millennium Management LLC, J. Goldman & Co LP, Jefferies Financial Group Inc., Group One Trading LLC, Focus Partners Wealth, Eisler Capital Management Ltd., D. E. Shaw & Co. Inc., Cresset Asset Management LLC, Cubist Systematic Strategies LLC, Bosun Asset Management LLC, Cantor Fitzgerald L. P., Capstone Investment Advisors LLC, Citadel Advisors LLC, Balyasny Asset Management L.P., Bank of America Corp DE, BNP Paribas Financial Markets, ADAPT Investment Managers SA, Jane Street Group LLC, Lido Advisors LLC, Parallax Volatility Advisers L.P., Diadema Partners LP, Susquehanna International Group LLP, HAP Trading LLC, Concourse Financial Group Securities Inc., PEAK6 LLC, Walleye Trading LLC, Walleye Capital LLC, Barclays PLC, Capital Fund Management S.A., Capula Management Ltd, Bank of Nova Scotia, Wells Fargo & Company MN, ExodusPoint Capital Management LP, JPMorgan Chase & Co., LPL Financial LLC, Simplex Trading LLC, Twin Tree Management LP, Delta Accumulation LLC, Marathon Trading Investment Management LLC, Allianz Asset Management GmbH, and Wolverine Asset Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for AbbVie?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.96% of AbbVie's floating shares are currently sold short.

Is AbbVie's short interest increasing or decreasing?

AbbVie saw a drop in short interest during the month of April. As of April 15th, there was short interest totaling 16,840,000 shares, a drop of 1.8% from the previous total of 17,140,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does AbbVie's short interest compare to its competitors?

0.96% of AbbVie's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to AbbVie: Eli Lilly and Company (0.76%), Johnson & Johnson (0.87%), Merck & Co., Inc. (1.67%), Pfizer Inc. (1.90%), Bristol-Myers Squibb (1.48%), Zoetis Inc. (1.74%), Royalty Pharma plc (6.15%), Corcept Therapeutics Incorporated (13.18%), Jazz Pharmaceuticals plc (7.81%), Perrigo Company plc (3.59%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks.

What does it mean to sell short AbbVie stock?

Short selling ABBV is an investing strategy that aims to generate trading profit from AbbVie as its price is falling. ABBV shares are trading up $5.28 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against AbbVie?

A short squeeze for AbbVie occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ABBV, which in turn drives the price of the stock up even further.

How often is AbbVie's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ABBV, twice per month. The most recent reporting period available is April, 15 2025.



Related Companies
Short Interest Tools

This page (NYSE:ABBV) was last updated on 5/5/2025 by MarketBeat.com Staff
From Our Partners
Elon’s Terrifying Warning Forces Trump To Take Action
Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...
American Hartford Gold | Sponsored
Warning: “DOGE Collapse” imminent
Elon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...
Altimetry | Sponsored
Trump’s Bitcoin Reserve is No Accident…
Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...
Crypto 101 Media | Sponsored
Shocking AI play that’s beats Nvidia by a country mile
You’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...
Timothy Sykes | Sponsored
Gold Hits New Highs as Global Markets Spiral
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...
Premier Gold Co | Sponsored
Donald Trump is about to free crypto from its chains …
Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...
Weiss Ratings | Sponsored
Musk's warning signal: Prepare before the cascade begins
When Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...
InvestorPlace | Sponsored
Elon Set to Shock the World on June 1st?
Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...
Brownstone Research | Sponsored